Recent ABOS News
- Acumen Pharmaceuticals to Report First Quarter Results on May 14, 2024 • GlobeNewswire Inc. • 05/07/2024 08:00:00 PM
- Acumen Pharmaceuticals Presents First Comprehensive Clinical and Biomarker Data for Sabirnetug (ACU193) at American Academy of Neurology 2024 Annual Meeting • GlobeNewswire Inc. • 04/16/2024 12:00:00 PM
- Acumen Pharmaceuticals Collaborates with Lonza to Advance Sabirnetug for the Treatment of Alzheimer’s Disease • GlobeNewswire Inc. • 04/04/2024 12:00:00 PM
- Acumen Pharmaceuticals Reports Financial Results for the Year Ended December 31, 2023 and Business Highlights • GlobeNewswire Inc. • 03/26/2024 11:00:00 AM
- Acumen Pharmaceuticals to Present Deeper Insights, Including Fluid Biomarker Data for Sabirnetug (ACU193), During Emerging Science Session at the American Academy of Neurology Annual Meeting • GlobeNewswire Inc. • 03/21/2024 12:00:00 PM
- Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2023 Financial Results on March 26, 2024 • GlobeNewswire Inc. • 03/19/2024 08:00:00 PM
- Acumen Pharmaceuticals to Participate in the Stifel 2024 CNS Days • GlobeNewswire Inc. • 03/12/2024 08:00:00 PM
- Acumen Pharmaceuticals Presents Sabirnetug (ACU193) Fluid Biomarker and Target Engagement Analyses from Phase 1 INTERCEPT-AD Study in Early Alzheimer’s at the AD/PD™ 2024 Annual Meeting • GlobeNewswire Inc. • 03/08/2024 01:50:00 PM
- Acumen Pharmaceuticals to Present Sabirnetug (ACU193) Fluid Biomarker and Target Engagement Analyses from Phase 1 INTERCEPT-AD Study in Early Alzheimer’s at the AD/PD™ 2024 Annual Meeting • GlobeNewswire Inc. • 02/21/2024 01:00:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 01:32:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/01/2024 10:02:07 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/01/2024 10:01:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 12:16:51 PM
- Acumen Pharmaceuticals Appoints Dr. James Doherty as President and Chief Development Officer • GlobeNewswire Inc. • 02/01/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/20/2024 12:07:42 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/20/2024 12:06:34 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/20/2024 12:05:54 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/20/2024 12:05:14 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/20/2024 12:04:18 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/19/2024 09:36:08 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/19/2024 09:35:19 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/18/2024 09:29:09 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/18/2024 09:28:26 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/18/2024 09:27:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2024 01:42:41 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM